PT  - JOURNAL ARTICLE
AU  - Mallikarjuna Ponnapa Reddy
AU  - Ashwin Subramaniam
AU  - Zheng Jie Lim
AU  - Alexandr Zubarev
AU  - Afsana Afroz
AU  - Baki Billah
AU  - Gabriel Blecher
AU  - Ravindranath Tiruvoipati
AU  - Kollengode Ramanathan
AU  - Suei Nee Wong
AU  - Daniel Brodie
AU  - Eddy Fan
AU  - Kiran Shekar
TI  - Prone positioning of non-intubated patients with COVID-19 - A Systematic Review and Meta-analysis
AID  - 10.1101/2020.10.12.20211748
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.12.20211748
4099  - http://medrxiv.org/content/early/2020/10/14/2020.10.12.20211748.short
4100  - http://medrxiv.org/content/early/2020/10/14/2020.10.12.20211748.full
AB  - Purpose Several studies have reported adopting prone positioning (PP) in non-intubated patients with COVID-19-related hypoxaemic respiratory failure. This systematic review and meta-analysis evaluated the impact of PP on oxygenation and clinical outcomes.Methods We searched PubMed, Embase and COVID-19 living systematic review from December1st 2019 to July23rd 2020. We included studies that reported using PP in hypoxaemic, non-intubated adult COVID-19 patients. Primary outcome measure was the weighted mean difference (MD) in oxygenation parameters (PaO2/FiO2, PaO2 or SpO2) pre and post-PP.Results Fifteen single arm observational studies reporting PP in 449 patients were included. Substantial heterogeneity was noted in terms of, location within hospital where PP was instituted, respiratory supports, frequency and duration of PP. Significant improvement in oxygenation was reported post-PP: PaO2/FiO2, (MD 37.6, 95%CI 18.8, 56.5); PaO2, (MD 30.4 mmHg, 95%CI 10.9, 49.9); and SpO2, (MD 5.8%, 95%CI 3.7, 7.9). Patients with a pre-PP PaO2/FiO2 ≤150 experienced greater oxygenation improvements compared with those with a pre-PP PaO2/FiO2 >150 (MD 40.5, 95%CI −3.5, 84.6) vs. 37, 95%CI 17.1, 56.9). Respiratory rate decreased post-PP (MD −2.9, 95%CI −5.4, −0.4). Overall intubation and mortality rates were 21% (90/426) and 26% (101/390) respectively. No major adverse events were reported.Conclusions Despite significant variability in frequency and duration of PP and respiratory supports, PP was associated with improvements in oxygenation parameters without any reported serious adverse events. Major limitation being lack of control arm and adjustment for confounders. Clinical trials are required to determine the effect of awake PP on patient-centred outcomes.Systematic review registration Registration/protocol in PROSPERO (CRD42020194080).What is the key question?Is the novel approach of prone positioning in non-intubated patients associated with improvement in oxygenation?What is the bottom line?Prone position in non-intubated severe COIVD 19 suffers is associated with improvement of oxygenation while the short- and long-term patient centred out comes in this awake prone patient need more investigation.Why read on?Our study is first of its kind (Systematic review and Meta-analysis) summarising the evidence surrounding the less invasive innovate technique of prone position in non-intubated COVID-19 patients.Competing Interest StatementDB reports research support from ALung Technologies, and personal fees from Baxter, Abiomed, and Xenios, as well as an unpaid relationship with Hemovent. EF reports personal fees from ALung Technologies, Fresenius Medical Care, Getinge, and MC3 Cardiopulmonary outside the submitted work. All other authors declare no support from any organization for the submitted work, no competing interests with regards to the submitted work. Clinical TrialPROSPERO (CRD42020194080)Funding StatementFunding: No funding sources to declareAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This Systematic review does not need IRB approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailability of data and material: All the data analysed in this study is included in the main article and supplementary files. Additional information that was obtained from some of the studies after contacting the authors is available from the corresponding author on reasonable request.